Evidence map›Paper›PMID 36145137›Full record

ReviewNutrients2022

Functional Alternatives to Alcohol.

David J Nutt, Robin J Tyacke, Meg Spriggs, Vanessa Jacoby, Alan D Borthwick, Delia Belelli

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David J NuttGABA Labs (Research) Ltd., Old Town Court, 70 Queensway, Suite 2, Hemel Hempstead HP2 5HD, UK.ORCID 0000-0002-1286-1401
Robin J TyackeGABA Labs (Research) Ltd., Old Town Court, 70 Queensway, Suite 2, Hemel Hempstead HP2 5HD, UK.
Meg SpriggsGABA Labs (Research) Ltd., Old Town Court, 70 Queensway, Suite 2, Hemel Hempstead HP2 5HD, UK.
Vanessa JacobyGABA Labs (Research) Ltd., Old Town Court, 70 Queensway, Suite 2, Hemel Hempstead HP2 5HD, UK.
Alan D BorthwickGABA Labs (Research) Ltd., Old Town Court, 70 Queensway, Suite 2, Hemel Hempstead HP2 5HD, UK.
Delia BelelliGABA Labs (Research) Ltd., Old Town Court, 70 Queensway, Suite 2, Hemel Hempstead HP2 5HD, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The consumption of alcohol is associated with well-known health harms and many governments worldwide are actively engaged in devising approaches to reduce them. To this end, a common proposed strategy aims at reducing alcohol consumption. This approach has led to the development of non-alcoholic drinks, which have been especially welcome by younger, wealthier, health-conscious consumers, who have been turning away from alcohol to look toward alternatives. However, a drawback of non-alcoholic drinks is that they do not facilitate social interaction in the way alcohol does, which is the main reason behind social drinking. Therefore, an alternative approach is to develop functional drinks that do not use alcohol yet mimic the positive, pro-social effects of alcohol without the associated harms. This article will discuss (1) current knowledge of how alcohol mediates its effects in the brain, both the desirable, e.g., antistress to facilitate social interactions, and the harmful ones, with a specific focus on the pivotal role played by the gamma-aminobutyric acid (GABA) neurotransmitter system and (2) how this knowledge can be exploited to develop functional safe alternatives to alcohol using either molecules already existing in nature or synthetic ones. This discussion will be complemented by an analysis of the regulatory challenges associated with the novel endeavour of bringing safe, functional alternatives to alcohol from the bench to bars.

Indexed as

Alcohol DrinkingEthanolBraingamma-Aminobutyric AcidEthanolgamma-Aminobutyric AcidalcoholbotanicalsethanolGABAGABAARgamma-aminobutyric acidsociability

Identifiers

PMID36145137
PMCPMC9505959
OpenAlexW4296588582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.